Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Pfizer,Axitinib,"Renal cell carcinoma, metastatic, clear cell, second line",Axitinib (Inlyta),Community and Hospital,Oncology Agents and Immunosuppressants
